bitBiome, Inc.: bitBiome and Kaken Pharmaceuticals sign joint research agreement on the discovery of drugs for infectious diseases

-The joint research will use bitBiome's drug discovery platform technology to search for drug candidate substances- TOKYO, March 29, 2023 /PRNewswire/ -- bitBiome, Inc. (Head office: Shinjuku-ku

Related Keywords

Tokyo ,Japan ,Kaken ,Niedersachsen ,Germany ,Bunkyo Ku ,Shinjuku Ku ,Hiroyuki Horiuchi ,Ryuji Suzuki ,Kaken Pharmaceuticals Head ,Ubiome Inc , ,Kaken Pharmaceuticals ,Long Term Business Plan ,Chief Executive Officer ,Diese Gold Aktie ,Sichern Sie ,Bitbiome ,Aken ,Pharmaceuticals ,Sign ,Joint ,Research ,Agreement ,Discovery ,Drugs ,Nfectious ,Diseases ,